Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Radiation Oncology Product Introduction
1.2 Global Radiation Oncology Market Size Forecast
1.3 Radiation Oncology Market Trends & Drivers
1.3.1 Radiation Oncology Industry Trends
1.3.2 Radiation Oncology Market Drivers & Opportunity
1.3.3 Radiation Oncology Market Challenges
1.3.4 Radiation Oncology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Radiation Oncology Players Revenue Ranking (2023)
2.2 Global Radiation Oncology Revenue by Company (2019-2024)
2.3 Key Companies Radiation Oncology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Radiation Oncology Product Offered
2.5 Key Companies Time to Begin Mass Production of Radiation Oncology
2.6 Radiation Oncology Market Competitive Analysis
2.6.1 Radiation Oncology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Radiation Oncology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Oncology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 External Beam Radiation Therapy (EBRT)
3.1.2 Brachytherapy
3.2 Global Radiation Oncology Sales Value by Type
3.2.1 Global Radiation Oncology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Radiation Oncology Sales Value, by Type (2019-2030)
3.2.3 Global Radiation Oncology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Blood Cancer (Leukaemia)
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Respiratory/Lung Cancer
4.1.5 Skin Cancer
4.1.6 Other Cancers
4.2 Global Radiation Oncology Sales Value by Application
4.2.1 Global Radiation Oncology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Radiation Oncology Sales Value, by Application (2019-2030)
4.2.3 Global Radiation Oncology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Radiation Oncology Sales Value by Region
5.1.1 Global Radiation Oncology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Radiation Oncology Sales Value by Region (2019-2024)
5.1.3 Global Radiation Oncology Sales Value by Region (2025-2030)
5.1.4 Global Radiation Oncology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Radiation Oncology Sales Value, 2019-2030
5.2.2 North America Radiation Oncology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Radiation Oncology Sales Value, 2019-2030
5.3.2 Europe Radiation Oncology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Radiation Oncology Sales Value, 2019-2030
5.4.2 Asia Pacific Radiation Oncology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Radiation Oncology Sales Value, 2019-2030
5.5.2 South America Radiation Oncology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Radiation Oncology Sales Value, 2019-2030
5.6.2 Middle East & Africa Radiation Oncology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Radiation Oncology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Radiation Oncology Sales Value
6.3 United States
6.3.1 United States Radiation Oncology Sales Value, 2019-2030
6.3.2 United States Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Radiation Oncology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Radiation Oncology Sales Value, 2019-2030
6.4.2 Europe Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Radiation Oncology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Radiation Oncology Sales Value, 2019-2030
6.5.2 China Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Radiation Oncology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Radiation Oncology Sales Value, 2019-2030
6.6.2 Japan Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Radiation Oncology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Radiation Oncology Sales Value, 2019-2030
6.7.2 South Korea Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Radiation Oncology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Radiation Oncology Sales Value, 2019-2030
6.8.2 Southeast Asia Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Radiation Oncology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Radiation Oncology Sales Value, 2019-2030
6.9.2 India Radiation Oncology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Radiation Oncology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Accuray
7.1.1 Accuray Profile
7.1.2 Accuray Main Business
7.1.3 Accuray Radiation Oncology Products, Services and Solutions
7.1.4 Accuray Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.1.5 Accuray Recent Developments
7.2 C. R. Bard
7.2.1 C. R. Bard Profile
7.2.2 C. R. Bard Main Business
7.2.3 C. R. Bard Radiation Oncology Products, Services and Solutions
7.2.4 C. R. Bard Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.2.5 C. R. Bard Recent Developments
7.3 Elekta
7.3.1 Elekta Profile
7.3.2 Elekta Main Business
7.3.3 Elekta Radiation Oncology Products, Services and Solutions
7.3.4 Elekta Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.3.5 IBA Worldwide Recent Developments
7.4 IBA Worldwide
7.4.1 IBA Worldwide Profile
7.4.2 IBA Worldwide Main Business
7.4.3 IBA Worldwide Radiation Oncology Products, Services and Solutions
7.4.4 IBA Worldwide Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.4.5 IBA Worldwide Recent Developments
7.5 Varian Medical Systems
7.5.1 Varian Medical Systems Profile
7.5.2 Varian Medical Systems Main Business
7.5.3 Varian Medical Systems Radiation Oncology Products, Services and Solutions
7.5.4 Varian Medical Systems Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.5.5 Varian Medical Systems Recent Developments
7.6 Carl Zeiss Meditec
7.6.1 Carl Zeiss Meditec Profile
7.6.2 Carl Zeiss Meditec Main Business
7.6.3 Carl Zeiss Meditec Radiation Oncology Products, Services and Solutions
7.6.4 Carl Zeiss Meditec Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.6.5 Carl Zeiss Meditec Recent Developments
7.7 iCAD
7.7.1 iCAD Profile
7.7.2 iCAD Main Business
7.7.3 iCAD Radiation Oncology Products, Services and Solutions
7.7.4 iCAD Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.7.5 iCAD Recent Developments
7.8 IsoRay
7.8.1 IsoRay Profile
7.8.2 IsoRay Main Business
7.8.3 IsoRay Radiation Oncology Products, Services and Solutions
7.8.4 IsoRay Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.8.5 IsoRay Recent Developments
7.9 Mevion Medical Systems
7.9.1 Mevion Medical Systems Profile
7.9.2 Mevion Medical Systems Main Business
7.9.3 Mevion Medical Systems Radiation Oncology Products, Services and Solutions
7.9.4 Mevion Medical Systems Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.9.5 Mevion Medical Systems Recent Developments
7.10 Nordion
7.10.1 Nordion Profile
7.10.2 Nordion Main Business
7.10.3 Nordion Radiation Oncology Products, Services and Solutions
7.10.4 Nordion Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.10.5 Nordion Recent Developments
7.11 NTP Radioisotopes
7.11.1 NTP Radioisotopes Profile
7.11.2 NTP Radioisotopes Main Business
7.11.3 NTP Radioisotopes Radiation Oncology Products, Services and Solutions
7.11.4 NTP Radioisotopes Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.11.5 NTP Radioisotopes Recent Developments
7.12 Canon Medical Systems
7.12.1 Canon Medical Systems Profile
7.12.2 Canon Medical Systems Main Business
7.12.3 Canon Medical Systems Radiation Oncology Products, Services and Solutions
7.12.4 Canon Medical Systems Radiation Oncology Revenue (US$ Million) & (2019-2024)
7.12.5 Canon Medical Systems Recent Developments
8 Industry Chain Analysis
8.1 Radiation Oncology Industrial Chain
8.2 Radiation Oncology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Radiation Oncology Sales Model
8.5.2 Sales Channel
8.5.3 Radiation Oncology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Radiation Oncology Market Trends
Table 2. Radiation Oncology Market Drivers & Opportunity
Table 3. Radiation Oncology Market Challenges
Table 4. Radiation Oncology Market Restraints
Table 5. Global Radiation Oncology Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Radiation Oncology Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Radiation Oncology Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Radiation Oncology Product Type
Table 9. Key Companies Time to Begin Mass Production of Radiation Oncology
Table 10. Global Radiation Oncology Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Oncology as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Radiation Oncology Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Radiation Oncology Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Radiation Oncology Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Radiation Oncology Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Radiation Oncology Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Radiation Oncology Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Radiation Oncology Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Radiation Oncology Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Radiation Oncology Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Radiation Oncology Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Radiation Oncology Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Radiation Oncology Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Radiation Oncology Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Radiation Oncology Sales Value by Region (2019-2024) & (%)
Table 27. Global Radiation Oncology Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Radiation Oncology Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Radiation Oncology Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Radiation Oncology Sales Value, (2025-2030) & (US$ Million)
Table 31. Accuray Basic Information List
Table 32. Accuray Description and Business Overview
Table 33. Accuray Radiation Oncology Products, Services and Solutions
Table 34. Revenue (US$ Million) in Radiation Oncology Business of Accuray (2019-2024)
Table 35. Accuray Recent Developments
Table 36. C. R. Bard Basic Information List
Table 37. C. R. Bard Description and Business Overview
Table 38. C. R. Bard Radiation Oncology Products, Services and Solutions
Table 39. Revenue (US$ Million) in Radiation Oncology Business of C. R. Bard (2019-2024)
Table 40. C. R. Bard Recent Developments
Table 41. Elekta Basic Information List
Table 42. Elekta Description and Business Overview
Table 43. Elekta Radiation Oncology Products, Services and Solutions
Table 44. Revenue (US$ Million) in Radiation Oncology Business of Elekta (2019-2024)
Table 45. Elekta Recent Developments
Table 46. IBA Worldwide Basic Information List
Table 47. IBA Worldwide Description and Business Overview
Table 48. IBA Worldwide Radiation Oncology Products, Services and Solutions
Table 49. Revenue (US$ Million) in Radiation Oncology Business of IBA Worldwide (2019-2024)
Table 50. IBA Worldwide Recent Developments
Table 51. Varian Medical Systems Basic Information List
Table 52. Varian Medical Systems Description and Business Overview
Table 53. Varian Medical Systems Radiation Oncology Products, Services and Solutions
Table 54. Revenue (US$ Million) in Radiation Oncology Business of Varian Medical Systems (2019-2024)
Table 55. Varian Medical Systems Recent Developments
Table 56. Carl Zeiss Meditec Basic Information List
Table 57. Carl Zeiss Meditec Description and Business Overview
Table 58. Carl Zeiss Meditec Radiation Oncology Products, Services and Solutions
Table 59. Revenue (US$ Million) in Radiation Oncology Business of Carl Zeiss Meditec (2019-2024)
Table 60. Carl Zeiss Meditec Recent Developments
Table 61. iCAD Basic Information List
Table 62. iCAD Description and Business Overview
Table 63. iCAD Radiation Oncology Products, Services and Solutions
Table 64. Revenue (US$ Million) in Radiation Oncology Business of iCAD (2019-2024)
Table 65. iCAD Recent Developments
Table 66. IsoRay Basic Information List
Table 67. IsoRay Description and Business Overview
Table 68. IsoRay Radiation Oncology Products, Services and Solutions
Table 69. Revenue (US$ Million) in Radiation Oncology Business of IsoRay (2019-2024)
Table 70. IsoRay Recent Developments
Table 71. Mevion Medical Systems Basic Information List
Table 72. Mevion Medical Systems Description and Business Overview
Table 73. Mevion Medical Systems Radiation Oncology Products, Services and Solutions
Table 74. Revenue (US$ Million) in Radiation Oncology Business of Mevion Medical Systems (2019-2024)
Table 75. Mevion Medical Systems Recent Developments
Table 76. Nordion Basic Information List
Table 77. Nordion Description and Business Overview
Table 78. Nordion Radiation Oncology Products, Services and Solutions
Table 79. Revenue (US$ Million) in Radiation Oncology Business of Nordion (2019-2024)
Table 80. Nordion Recent Developments
Table 81. NTP Radioisotopes Basic Information List
Table 82. NTP Radioisotopes Description and Business Overview
Table 83. NTP Radioisotopes Radiation Oncology Products, Services and Solutions
Table 84. Revenue (US$ Million) in Radiation Oncology Business of NTP Radioisotopes (2019-2024)
Table 85. NTP Radioisotopes Recent Developments
Table 86. Canon Medical Systems Basic Information List
Table 87. Canon Medical Systems Description and Business Overview
Table 88. Canon Medical Systems Radiation Oncology Products, Services and Solutions
Table 89. Revenue (US$ Million) in Radiation Oncology Business of Canon Medical Systems (2019-2024)
Table 90. Canon Medical Systems Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Radiation Oncology Downstream Customers
Table 94. Radiation Oncology Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Radiation Oncology Product Picture
Figure 2. Global Radiation Oncology Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 4. Radiation Oncology Report Years Considered
Figure 5. Global Radiation Oncology Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiation Oncology Revenue in 2023
Figure 7. Radiation Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. External Beam Radiation Therapy (EBRT) Picture
Figure 9. Brachytherapy Picture
Figure 10. Global Radiation Oncology Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Radiation Oncology Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Blood Cancer (Leukaemia)
Figure 13. Product Picture of Breast Cancer
Figure 14. Product Picture of Gastrointestinal Cancer
Figure 15. Product Picture of Respiratory/Lung Cancer
Figure 16. Product Picture of Skin Cancer
Figure 17. Product Picture of Other Cancers
Figure 18. Global Radiation Oncology Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Radiation Oncology Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Radiation Oncology Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Radiation Oncology Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Radiation Oncology Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Radiation Oncology Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Radiation Oncology Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Radiation Oncology Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Radiation Oncology Sales Value (%), (2019-2030)
Figure 31. United States Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 37. China Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 39. China Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 49. India Radiation Oncology Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Radiation Oncology Sales Value by Type (%), 2023 VS 2030
Figure 51. India Radiation Oncology Sales Value by Application (%), 2023 VS 2030
Figure 52. Radiation Oncology Industrial Chain
Figure 53. Radiation Oncology Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation